Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Feb 25, 2026, before the open
10-K filed Feb 26, 2026, 57 days after period end · 0000874015-26-000115
| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $203.33M | $226.58M | $324.51M | $151.89M |
| Net Income | -$229.39M | -$104.35M | -$9.26M | -$52.43M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$1.41 |
| -$0.66 |
| -$0.06 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.